Enhanced Anti-tumour Effect of Cisplatin with Low-voltage Electrochemotherapy in Hamster Oral Fibrosarcoma

The aim of this study was to determine the effects of low-voltage electrochemotherapy with intraperitoneal cisplatin on hamster oral fibrosarcoma. Oral fibrosarcoma was transplanted sub-mucosally into the cheek pouch mucosa of 100 hamsters. After transplantation, the hamsters were randomly divided into four equal groups. These groups received no treatment (D-E-); 2 mg/kg body weight cisplatin treatment without electroporation (D+E-); electroporation without cisplatin treatment (D-E+);or 2 mg/kg body weight cisplatin treatment followed by electroporation (D+E+). Electrical pulse treatment together with cisplatin injection markedly reduced the size of the tumour, whereas cisplatin injection or electrical pulse treatment alone did not. These results clearly indicate that the anti-tumour effect of cisplatin on hamster oral fibrosarcoma was considerably potentiated or enhanced by the administration of local electrical pulses at low voltages.

[1]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  D. Miklavcic,et al.  Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. , 1998, British Journal of Cancer.

[3]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases , 2000, Melanoma research.

[4]  S. Orlowski,et al.  Mechanisms of electrochemotherapy. , 1999, Advanced drug delivery reviews.

[5]  K. Takaoka,et al.  Low-Voltage Electrochemotherapy with Low-Dose Methotrexate Enhances Survival in Mice with Osteosarcoma , 2004, Clinical orthopaedics and related research.

[6]  L. Mir,et al.  Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model. , 2001, European journal of cancer.

[7]  M Cemazar,et al.  Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin , 2002, British Journal of Cancer.

[8]  Richard Heller,et al.  Electrochemotherapy, electrogenetherapy, and transdermal drug delivery : electrically mediated delivery of molecules to cells , 2000 .

[9]  H. Matsubara,et al.  Possible Involvement of Antitumor Immunity in the Eradication of Colon 26 Induced by Low-Voltage Electrochemotherapy with Bleomycin , 2003, Surgery Today.

[10]  M. Jaroszeski,et al.  Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin , 1998, Cancer.

[11]  T. Nikaido,et al.  Enhancement of antitumor effect of bleomycin by low‐voltage in vivo electroporation: A study of human uterine leiomyosarcomas in nude mice , 2000, International journal of cancer.

[12]  L. Milas,et al.  Kinetics of cisplatin‐induced apoptosis in murine mammary and ovarian adenocarcinomas , 1995, International journal of cancer.

[13]  L. Mir,et al.  Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. , 1994, Biochimica et biophysica acta.

[14]  D. Miklavčič,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0222 , 2022 .

[15]  G. Serša,et al.  Electrochemotherapy : animal model work review. , 2000, Methods in molecular medicine.

[16]  S. Rodriguez-Cuevas,et al.  Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. , 2001, Archives of medical research.